BLFS - BioLife Solutions Inc

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the gene and cell therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company is headquartered in Bothell, Washington.

52W High

$29.55

52W Low

$19.10

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

1.78

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

294.12

EV/EBITDA (<8 favorable)

69.36

EV/Revenue (<3 favorable)

12.94

P/S (TTM) (<3 favorable)

13.56

P/B (<3 favorable)

3.65

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

2.11%

Institutions (25–75% balanced)

104.45%

Shares Outstanding

47,905,300

Float

39,409,700

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

93,468,000

Gross Profit (TTM)

60,443,000

EPS (TTM)

-0.40

Profit Margin (>10% good)

-0.06%

Operating Margin (TTM) (higher better)

-0.04%

ROE (TTM) (>15% strong)

-0.06%

EPS YoY (Quarterly) (>10% good)

6.40

Revenue YoY (Quarterly) (>8% good)

0.29

Momentum

Bearish momentum

Value

0.9977

0.9305

Trend

Rising

Signal Cross

No cross

As of

Sep. 05, 2025